An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts said the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Response and Content Removal
According to TikTok, the platform has removed violative material and banned associated keywords and query recommendations. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.
Within minutes of joining one group, a seller shared WhatsApp details, where most purchases take place. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Item Information and Pricing
Within these communities, messages show dark colored packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service stated it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to potentially significant health risks”.
